It was reported the procedure was to a de novo lesion with moderate tortuosity and moderate calcification in the distal renal artery.A 7.0 x 15 mm herculink elite was advanced, but missed 30% of the lesion due to during deployment the patient coughed.A second 7.0 x 15 mm herculink elite was advanced, but could not cross the herculink elite implanted stent.A 6.0 x 15 mm herculink elite was able to cross the lesion and the procedure was completed successfully.There was no interaction of devices reported.There was no adverse patient effect.No additional information was provided.
|
(b)(4).It is indicated that the device is not returning for evaluation; therefore a failure analysis of the complaint device could not be completed.Based on the reported information, there is no indication of a product quality issue with respect to manufacture, design, or labeling.The reported difficulties appear to be related to operational context.A review of the lot history record revealed no non-conformances.A query of the electronic complaint handling database revealed no other incidents reported from this lot.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design, or labeling.
|